LIDOCAINE HYDROCHLO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
DLA award SPE2DP21F5831 is a delivery order issued to DMS Pharmaceutical Group Inc under the primary contract SPE2DX15D9383 for the procurement of Lidocaine Hydrochlo. The overarching contract, originally awarded on April 30, 2015, was established for commercial items with a total schedule amount of 4,999,999.00 dollars and includes standard FAR clauses regarding defense priority and transportation requirements. Despite the initial award notice, modification P00001 dated August 25, 2026, resulted in the total cancellation of the order. This modification cancelled CLIN 0001 at no cost, reducing the total order amount from 94.96 dollars to 0.00 dollars. This action was taken as part of a mutual agreement between the government and the contractor to cancel aged, undelivered, and non-performing delivery orders.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
